SCHEMBL6950419

SCHEMBL6950419

CCOc1ccccc1N/C=C1\C(=O)N(c2ccc(S(N)(=O)=O)cc2)N=C1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.60
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA9 Q16790 2/20 0.52
KAT8 Q9H7Z6 2/20 0.52
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
CA12 O43570 1/20 0.42
GAA P10253 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950421 1.00 PTGS2 (0.60) PTGS2CA1CA2CA9KAT8
SCHEMBL8427561 0.95 PTGS2 (0.56) PTGS2CA1CA2CA9KAT8
SCHEMBL8427560 0.95 PTGS2 (0.56) PTGS2CA1CA2CA9KAT8
SCHEMBL9525776 0.89 ALDH1A1 (0.53) PTGS2ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL6951766 0.89 PTGS2 (0.47) PTGS2CA1CA2CA9KAT8
SCHEMBL8009451 0.89 PTGS2 (0.47) PTGS2CA1CA2CA9KAT8
SCHEMBL6949544 0.88 PTGS2 (0.47) PTGS2CA1CA2CA9KAT8
SCHEMBL6949542 0.88 PTGS2 (0.47) PTGS2CA1CA2CA9KAT8
SCHEMBL6942491 0.86 PTGS2 (0.47) PTGS2CA1CA2CA9KAT8
SCHEMBL6942495 0.86 PTGS2 (0.47) PTGS2CA1CA2CA9KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed